Street Drugs: EMS Guide to Emerging Overdose Threats

Added:

The Harm Reduction and Proactive Drug-Checking Paradigm

While the traditional EMS model focuses on reactive, clinical management of overdoses and identifying specific 'emerging' toxidromes, the harm reduction paradigm advocates for proactive, user-centered interventions. Proponents argue that relying on emergency response after ingestion is a structural failure that treats the symptoms rather than the cause of drug-related harms. Instead, they emphasize strategies like community-based drug-checking services, supervised consumption sites, and peer-led distribution of harm reduction supplies. Furthermore, sociologists and public health advocates critique the 'emerging drug threat' narrative (focusing on sensationalized media targets like 'krokodil' or 'bath salts') as a driver of moral panic. They argue this focus distracts from systemic issues—such as the toxic unregulated drug supply and socio-economic distress—while inadvertently fostering provider bias and stigmatizing patients. They advocate for structural policy reform, decriminalization, and safe supply initiatives over purely reactive medical protocols.

Basic physiology of the Autonomic Nervous System (ANS), specifically the sympathetic and parasympathetic pathways.
Foundational principles of pharmacology, including receptor theory (agonists and antagonists) and pharmacodynamics.
Standard emergency medical assessment protocols, such as evaluating airway, breathing, circulation (ABCs) and vital signs.
An introductory understanding of classic clinical toxidromes (e.g., opioid, sympathomimetic, and sedative-hypnotic profiles).
Advanced pre-hospital management of Excited Delirium Syndrome (ExDS) and severe drug-induced agitation.
The public health and epidemiological tracking methodologies for Novel Psychoactive Substances (NPS).
Clinical wound management and surgical debridement protocols for necrotizing drug contaminants, such as desomorphine (crocodyl).
Forensic toxicology principles and the regulatory frameworks, such as the Federal Analogue Act, used to identify and control synthetic drug variants.
152 views0likes35:40@ohiohealthemsOriginal Release: 2014-04-21

Emergency physicians should approach drug overdoses by first stabilizing the patient's airway, breathing, and circulation, then identifying the drug through toxidrome recognition (sympathomimetic, anticholinergic, cholinergic, opiate/sedative, or serotonin syndrome), with treatment being primarily supportive care and specific antidotes like naloxone for opiates, flumazenil for benzodiazepines, and atropine for organophosphates; newer drugs like bath salts (mephedrone), K2/K3 (synthetic cannabinoids), and hand sanitizer (isopropyl alcohol) require specific recognition due to their unique toxicity profiles and potential for severe complications.